© 2023 MJH Life Sciences™ and Urology Times. All rights reserved.
A recent study demonstrated that long-term, low-dose trimethoprim-sulfamethoxazole (TMP-SMX) was associated with a modest decrease in urinary tract infections (UTIs) in children who had had at least 1 such symptomatic infection in the past.